This log displays Freedom of Information (FOI) requests and our response to them. Requests are shown in the order in which they were received. Please note:

  • the information is only accurate on the date of each response
  • the hyperlinks contained in these documents were correct at the time of publishing but they can change over time
  • we carry out redactions on disclosure letters to protect the identity of individuals
     

If you would like more information about our disclosure log, please call the Information Governance Department on 01228 608998 or email FOIRequests@ncic.nhs.uk

Search files

Title
FOI 2021 0039 Patients treated regardless of disease Details

Description

FOI 2021 0057 prescribing in Ophthalmology Details

Description

FOI 2021 0066 Controlled Dug Denture Kit Details

Description

FOI 2021 0111 Atopic Dermatitis Details

Description

FOI 2021 0133 Apremilast Details

Description

FOI 2021 0148 Prescribing in Asthma_20200828 Details

Description

FOI 2021 0151 Atopic Dermatitis Details

Description

FOI 2021 0153 Anti INF Details

Description

FOI 2021 0187 Bacterial and fungal infections Details

Description

FOI 2021 0212 Prescribing in Rheumatology Details

Description

FOI 2021 0234 Biologic drugs Details

Description

FOI 2021 0251 incidence and treatment of melanoma and breast cancer Details

Description

FOI 2021 0260 Multiple Sclerosis Details

Description

FOI 2021 0267 Lung Cancer Details

Description

FOI 2021 0274 Medicinal Cannabis prescriptions Details

Description

FOI 2021 0308 Treatment of Head & Neck Cancer (H&N) and Renal Cancer (RCC) Details

Description

FOI 2021 0320 Viscosupplementation injections Details

Description

FOI 2021 0328 Treatment of Colorectal Cancer Details

Description

FOI 2021 0348 intra-vitreal injections and implants Details

Description

FOI 2021 0359 Anti - VEFG Treatments for eye conditions Details

Description

FOI 2021 0365 Treatment of Prostate and Ovarian Cancer Details

Description

FOI 2021 0373 Prescribing in growth hormone & acromegaly.docx Details

Description

FOI 2021 0373 Prescribing in growth hormone & acromegaly Details

Description

FOI 2021 0386 Migraine Details

Description

FOI 2021 0409 Dermatological Conditions Details

Description

FOI 2021 0421 Myelofibrosis and Oesophageal cancer Details

Description

FOI 2021 0469 biologic products for the treatment of severe asthma Details

Description

FOI 2021 0485 Usage of the drug Bevacizumab Details

Description

FOI 2021 0494 biologic and biosimilar products within Rheumatology Details

Description

FOI 2021 0501 Treatment on Neurology patients Details

Description

FOI 2021 0513 Drug spend and wastage Details

Description

FOI 2021 0523 Paediatric usage of Buccolam for pre-meddiagnostic use Details

Description

FOI 2021 0541 usage of anti-VEFG treatments for eye conditions. Details

Description

FOI 2021 0556 Patients Prescribed Details

Description

FOI 2021 0565 Hereditary Angioedema (HAE) Details

Description

FOI 2021 0566 Biologic drugs Details

Description

FOI 2021 0627 Dermatological conditions Details

Description